// App-Quantinova.ai

: Concomitant Use of Blinatumomab and Donor Lymphocyte Infusion for Post-Transplant Relapsed CD19 Positive Acute Lymphoblastic Leukemia: Systematic Review

Researchers

Presenter

  • Ceren Durer

Principal Investigators

  • Seren Durer

  • Madeeha Shafqat

  • Zunairah Shah

  • Maryam Sadiq

  • Muhammad Asad Fraz

  • Malik Qistas Ahmad

  • Hafiz Muhammad Fazeel

  • Sharoon Samuel

  • Mustafa Nadeem Malik

  • Midhat Lakhani

  • Chaudhry Saad Sohail

  • Anum Qureshi

  • Faiz Anwer

Medical Centers

  • Department of Medicine, Division of Hematology/Oncology, University of Arizona Cancer Center, Tucson, AZ

  • Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Cluster of Differentiation 19

Drug/Treatment

  • Blinatumomab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved